Evidence map›Paper›PMID 37511195›Full record

ArticleInternational journal of molecular sciences2023

A Comparative Analysis of Neuroprotective Properties of Taxifolin and Its Water-Soluble Form in Ischemia of Cerebral Cortical Cells of the Mouse.

Elena G Varlamova, Nina I Uspalenko, Natalia V Khmil, Maria I Shigaeva, Mikhail R Stepanov, Mikhail A Ananyan, Maria A Timchenko, Maxim V Molchanov, Galina D Mironova, Egor A Turovsky

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Elena G VarlamovaInstitute of Cell Biophysics, Russian Academy of Sciences, Pushchino 142290, Russia.ORCID 0000-0003-1158-5174
Nina I UspalenkoInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino 142290, Russia.
Natalia V KhmilInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino 142290, Russia.ORCID 0000-0002-3335-9269
Maria I ShigaevaInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino 142290, Russia.
Mikhail R StepanovAdvanced Technologies Ltd., Moscow 119333, Russia.
Mikhail A AnanyanAdvanced Technologies Ltd., Moscow 119333, Russia.
Maria A TimchenkoInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino 142290, Russia.ORCID 0000-0003-2547-8804
Maxim V MolchanovInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino 142290, Russia.
Galina D MironovaInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino 142290, Russia.
Egor A TurovskyInstitute of Cell Biophysics, Russian Academy of Sciences, Pushchino 142290, Russia.
Institute of Theoretical and Experimental Biophysics · RUInstitute of Cell Biophysics · RU

Funding

Russian Scientific Foundation 23-25-00441
6 · The paper itself

Abstract

Cerebral ischemia, and, as a result, insult, attacks up to 15 million people yearly in the world. In this connection, the development of effective preventive programs and methods of therapy has become one of the most urgent problems in modern angiology and pharmacology. The cytoprotective action of taxifolin (TAX) in ischemia is well known, but its limitations are also known due to its poor solubility and low capacity to pass through the hematoencephalic barrier. Molecular mechanisms underlying the protective effect of TAX in complex systems such as the brain remain poorly understood. It is known that the main cell types of the brain are neurons, astrocytes, and microglia, which regulate the activity of each other through neuroglial interactions. In this work, a comparative study of cytoprotective mechanisms of the effect of TAX and its new water-soluble form aqua taxifolin (aqTAX) was performed on cultured brain cells under ischemia-like conditions (oxygen-glucose deprivation (OGD)) followed by the reoxygenation of the culture medium. The concentration dependences of the protective effects of both taxifolin forms were determined using fluorescence microscopy, PCR analysis, and vitality tests. It was found that TAX began to effectively inhibit necrosis and the late stages of apoptosis in the concentration range of 30-100 µg/mL, with aqTAX in the range of 10-30 µg/mL. At the level of gene expression, aqTAX affected a larger number of genes than TAX; enhanced the basic and OGD/R-induced expression of genes encoding ROS-scavenging proteins with a higher efficiency, as well as anti-inflammatory and antiapoptotic proteins; and lowered the level of excitatory glutamate receptors. As a result, aqTAX significantly inhibited the OGD-induced increase in the Ca

Indexed as

Brain IschemiaNeuroprotective AgentsAnimalsCells, CulturedCell SurvivalGlucoseIschemiaMiceNeuronsOxygenQuercetinSignal TransductionGlucoseNeuroprotective AgentsOxygenQuercetintaxifolinapoptosisaqua taxifolinastrocytescalciumcortexgene expressionnecrosisneuronsoxygen–glucose deprivationreoxygenationtaxifolin

Identifiers

PMID37511195
PMCPMC10380368
OpenAlexW4384339374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.